X4 Pharmaceuticals, Inc (XFOR) stock forecast and price target
Price $3.12 · data as of November 13, 2026
12-month price target
Average target$11.60
Upside / downside+271.8%
Analysts5
ConsensusStrong buy
Low $10.00Average $11.60High $13.00
Gold marker: average target · white marker: today’s price ($3.12)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.64 | +65.6% | $17M |
| Next fiscal year ends December 31, 2027 | $-0.77 | −19.3% | $12M |
| Next quarter ends December 31, 2026 | $-0.21 | +4.6% | $3M |
| Quarter after ends March 31, 2027 | $-0.19 | −18.8% | $2M |
Consensus of the analysts covering X4 Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the X4 Pharmaceuticals stock price target?
The average 12-month target from 5 analysts is $11.60, 271.8% above the current price of $3.12 Targets range from $10.00 to $13.00.
Is X4 Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is X4 Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.64 for the fiscal year ending December 31, 2026 and $-0.77 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.